Clinical trials
Phase 2 Myasthenia Gravis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 6 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 3 |
| argenx | 3 |
| Grifols Therapeutics LLC | 2 |
| Momenta Pharmaceuticals, Inc. | 2 |
| Amgen | 1 |
| Cartesian Therapeutics | 1 |
| Cytokinetics | 1 |
| DAS-MG, Inc | 1 |
| Dianthus Therapeutics | 1 |
| Fred Hutchinson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 26 |
| Autoimmune Diseases | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Lambert-Eaton Myasthenic Syndrome | 1 |
| Neuromyelitis Optica | 1 |
| Opsoclonus-Myoclonus Syndrome | 1 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 |
| Stiff-Person Syndrome | 1 |
| Vasculitis, Central Nervous System | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.